Welcome to the Center for Sickle Cell Disease

Sickle Cell Adult Transition Website

Transitioning from pediatric to adult providers is an essential step in the care of teens and young adults with sickle cell anemia. The Howard University, Center for Sickle Cell Disease, Adult Transition Program works to educate children and young adults about their disease and personal medical history and develop skill sets required to navigate the adult health care setting.
 Learn more HERE

 

Howard University's Center for Sickle Cell Disease (SCD) was founded by the late Dr. Roland B. Scott in 1971 to address the needs of patients and families in the Washington Metropolitan area affected by SCD. The Center is committed to a six-fold goal that includes comprehensive medical care, research, testing, education, counseling, and community outreach. Recently, the Center has expanded its clinical research program and developed a collaborative consortium with Children’s National Medical Center (CNMC) and in working together with Howard University Hospital and NIH we are the Washington area’s leading provider of patient services for SCD.

 

*************************************************************************

Pain in Sickle Cell Disease: Pain: Myths, Facts, and Stigma

Tuesday, May 7, 2013 from 12:00pm – 5:00pm
Basement Auditorium
Howard University Hospital
2041 Georgia Ave NW
Washington, DC 20060

All Are Welcome to Attend,
Lunch will be included and donations are accepted.

Visit the event page to learn more.

 

View Webcast

 

*************************************************************************

*************************************************************************

 

Learn About the History of Sickle Cell Disease

A Brief History of Sickle Cell Disease by William P. Winter, Ph.D.

*************************************************************************

Sickle Cell and Anemia News (Archive)

  • Sickle Cell Disease In Adults Reversed By Blood Stem-Cell Transplant Regimen. A modified blood adult stem-cell transplant regimen has effectively reversed sickle cell disease in 9 of 10 adults who had been severely affected by the disease, according to results of a National Institutes of Health study in the Dec. 10 issue of the New England Journal of Medicine. The trial was conducted at the NIH Clinical Center in Bethesda, Md., by NIH researchers at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Heart, Lung and Blood Institute (NHLBI), and the National Institute of Allergy and Infectious Diseases. News from NIH News (posted December 9, 2009).

*** CLICK HERE TO JOIN US ON FACEBOOK! ***

 

Last updated: August 22, 2013